A Glucose Monitor for Someone Without Diabetes: Optimal or Overkill?
Two weeks ago, I used an applicator with an intimidating needle to lodge a tiny wire into the back of my arm. Since then, the sensor has sent my blood-sugar levels to my phone every 15 minutes.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Entrepreneur
2 minutes ago
- Entrepreneur
Milad Monshipour
Bio Milad Monshipour is a passionate tech entrepreneur and bold innovation strategist known for building game-changing ventures in some of the world's most complex markets. From taking Iran's first tech startup to IPO, to now reshaping how real estate is bought and sold through AI, Milad's founder journey is anything but ordinary. He is currently the Founder and CEO of AIR (AI Realtor), an ambitious AI-powered real estate brokerage based in the UAE that's reimagining the future of property transactions. With AIR, Milad is bringing to life his next big vision: to eliminate the friction, inefficiency, and confusion of real estate through intelligent digital journeys, starting in Dubai, and expanding globally. With a career that spans global consultancy and high-growth entrepreneurship, Milad's professional journey began at Booz Allen Hamilton in the UAE, where he advised leading government entities like ADNOC and Masdar City on national transformation, innovation, and infrastructure development. He later joined Boston Consulting Group (BCG) and Bain & Company, working across North America with Fortune 500 clients on strategic growth and operational transformation. But his true calling was building, not advising. Milad returned to his home country of Iran to co-found TAPSI, a ride-hailing platform that scaled to over 30 million passengers, 2.5 million drivers, and 500,000+ daily rides. Under his leadership, TAPSI became the first tech company in Iran to go public via IPO, making history and setting a new precedent for the region's startup ecosystem. The company was later successfully acquired by Golrang Industrial Group, delivering up to 8.5x returns to investors - a rare, full-cycle exit story in the Middle East tech landscape. Milad holds a Bachelor's Degree in Mechanical Engineering and an MBA from HEC Paris, one of Europe's leading business schools. Today, he continues to channel his passion for innovation into building scalable, AI-driven solutions that address real-world needs, starting with the real estate sector in the UAE and beyond.
Medscape
2 minutes ago
- Medscape
Lifestyle Changes After Colonoscopy May Lower CRC Risk
TOPLINE: Individuals who adopted a healthier lifestyle after their first screening colonoscopy had a lower risk for both colorectal cancer (CRC) and major chronic diseases. METHODOLOGY: Previous research has shown that lifestyle modifications after polypectomy can lower the risk for CRC, but the effect of such changes following screening colonoscopy remains unclear. Researchers prospectively analyzed data from three large US cohort studies (two Nurses' Health Study cohorts and one Health Professionals Follow-up Study) to assess the effect of lifestyle changes made after screening colonoscopy on the incidence of CRC and major chronic diseases. Participants (mean age post-screening, 63 years; 84% women) were asked biennially in a questionnaire whether they'd had a colonoscopy in the past 2 years and the reason for the procedure. Those who reported a diagnosis of CRC before screening were excluded. Researchers created a lifestyle score based on five modifiable risk factors for CRC: smoking, BMI, physical activity, alcohol intake, and diet. Each lifestyle criterion that was met was worth one point, resulting in a scale of 0-5, with a higher score reflecting a healthier lifestyle. Lifestyle was assessed before colonoscopy and after screening over time, and changes in lifestyle scores and factors were calculated. TAKEAWAY: A total of 118,396 individuals were analyzed for the incidence of CRC and 88,558 for the incidence of chronic diseases, and 537 incident cases of CRC and 14,165 of major chronic diseases (including cancer, cardiovascular disease and type 2 diabetes) were documented over median follow-up of 10 and 9.6 years, respectively. A one-unit increase in the healthy lifestyle score post-screening was associated with a 14% lower risk for CRC (P = .002) and an 11% lower risk for major chronic diseases (P < .0001), with the strongest disease-specific association for type 2 diabetes (P < .0001). Participants whose lifestyle score fell two points or more vs those with no change in score had a higher risk for CRC (hazard ratio, 1.7), with a stronger association noted for distal vs proximal CRC. Among individual lifestyle factors, increased physical activity was associated with reduced risks for CRC and major chronic diseases, whereas weight loss and diet changes were linked to a lower risk for major chronic diseases only. IN PRACTICE: 'Our findings support CRC screening as a valuable teachable moment for encouraging lifestyle improvements to not only enhance CRC prevention but also reduce the risk of other major chronic diseases,' the authors wrote. SOURCE: The study, led by Markus Dines Knudsen, PhD, Harvard T.H. Chan School of Public Health, Boston, was published online in the American Journal of Gastroenterology. LIMITATIONS: Residual confounding could not be ruled out due to the observational nature of the study. Self-reported data on screening and risk factors may have introduced measurement errors. Stratification by risk level was not done owing to the small number of CRC cases. The participant pool mainly consisted of White health professionals, thereby limiting the generalizability of the findings. DISCLOSURES: This study was supported by grants to various authors from the US National Institutes of Health, the American Cancer Society, Norwegian Cancer Society, the German Research Foundation, the Astri and Birger Torsted Endowment, and the Throne Holst Nutrition Research Foundation. One author disclosed consulting for Boehringer Ingelheim and Pfizer, Inc. and receiving grant support from Pfizer, Zoe Ltd., and Freenome for work outside of this study. Another author reported serving as a consultant for Etiome Inc. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Medscape
2 minutes ago
- Medscape
Posthospital Therapy Lowers Risk of Eating Disorder Relapse
TOPLINE: Among young people with eating disorders, receipt of four to seven sessions of outpatient therapy in the 90 days after hospital discharge lowered the risk for rehospitalization during the following 3 months, with a greater reduction in risk among those who received nearly one session per week. METHODOLOGY: Researchers analyzed data of youth with eating disorders from California's Medicaid program, Medi-Cal, to examine whether outpatient therapy after an initial hospitalization for eating disorder treatment could reduce repeated readmissions. More than 900 individuals aged 7-18 years (82.1% girls) who were diagnosed with at least one eating disorder and were hospitalized at least once between January 2014 and December 2016 were included. The number of outpatient therapy sessions received within 90 days post-hospitalization was analyzed and categorized as low (zero to three sessions), moderate (four to seven sessions), or high (eight or more sessions); rehospitalizations over subsequent 90 days were assessed. TAKEAWAY: Compared with individuals receiving zero to three sessions of therapy after discharge, those who received eight or more sessions had the lowest rate of rehospitalization (hazard ratio [HR], 0.04; P = .003), followed by those who received four to seven sessions (HR, 0.46; P = .026). Those who received eight or more sessions of therapy had a significantly lower risk for rehospitalization than those who received four to seven sessions (P = .024). Only 4.5% of participants received eight or more sessions of outpatient therapy. IN PRACTICE: '[The study] findings suggest that prompt access to regular outpatient therapy may be critical for disrupting cycles of repeated rehospitalizations, supporting recovery, and reducing costs for publicly insured youth,' the authors of the study wrote. SOURCE: This study was led by Megan E. Mikhail, MA, of the Department of Psychiatry and Behavioral Sciences at the University of California, San Francisco. It was published online on July 25, 2025, in Pediatrics. LIMITATIONS: Participants were not randomly assigned to receive different levels of therapy after hospitalization. Claims data did not specify whether therapy sessions targeted symptoms of eating disorders, general distress, or followed evidence-based protocols. DISCLOSURES: This study received support through a donation from the Deb family and a grant from the National Institute of Mental Health. One author reported serving as a consultant with Partnership HealthPlan of California. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
